74 49

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis

Title
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
Author
김태형
Keywords
Idiopathic Pulmonary Fibrosis; Diagnosis; Disease Management; Korea
Issue Date
2019-04
Publisher
The Korean Academy of Tuberculosis and Respiratory Diseases
Citation
Tuberculosis and Respiratory Diseases, v. 82, NO 2, Page. 102-117
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
URI
https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0091http://repository.hanyang.ac.kr/handle/20.500.11754/110782
ISSN
1738-3536; 2005-6184
DOI
10.4046/trd.2018.0091
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases Part 2. Idiopathic Pulmonary Fibrosis.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE